Business Context and Reporting Period
Company: HALOZYME THERAPEUTICS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: November 2, 2021
Reporting Period: Third Quarter ended September 30, 2021
Business Context: The filing serves to announce the issuance of a press release detailing the company's financial results for the third quarter of 2021.
Key Financial Metrics
This Form 8-K is a notification of a press release and does not contain specific financial data within the text of the filing itself. The following metrics are referenced as being contained in the attached press release (Exhibit 99.1) but are not explicitly stated in this document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only indicates that such results were reported in the attached press release.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on November 2, 2021, which contains the company's results and likely includes management commentary, though the content is not reproduced in this 8-K text.
Legal Status of Exhibit: The press release (Exhibit 99.1) is furnished under Item 2.02 and is explicitly not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section nor incorporated by reference in other filings.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 2, 2021) for actual revenue, net income, and cash flow figures for Q3 2021.
- Verify the company's forward-looking statements and guidance, which are contained in the press release rather than this 8-K.
- Note that the press release is not legally "filed" under Section 18 of the Exchange Act, which may affect liability standards for the information contained therein.
- Confirm the trading symbol HALO on The Nasdaq Stock Market LLC for current market data.